Pfizer and BioNTech submitted an application for emergency use authorization to the US Food and Drug Administration for an additional booster dose of their Covid-19 vaccine for adults 65 and older who ...

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

The Food and Drug Administration on Tuesday authorized a second booster of Pfizer-BioNTech and Moderna for adults 50 years and older, announcing that a fourth shot improves protection against severe ...

A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech said Friday.

Nov. 18 (UPI) --Pfizer and BioNTech said Friday their latest Omicron BA.4/BA.5-adapted bivalent COVID-19 booster vaccine also shows effectiveness against new subvariants of the virus. The companies ...

A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...

Credit: Getty Images. This age group is now eligible to receive the booster dose at least 2 months after they complete primary vaccination with 3 doses of the monovalent vaccine. The Food and Drug ...

Pfizer and BioNTech have submitted a request to the FDA for Emergency Use Authorization of an omicron-adapted COVID-19 booster dose for individuals 12 years of age and older. Pending authorization, ...

FILE PHOTO: Pfizer's logo is reflected in a drop on a syringe needle in this illustration (Reuters) - Pfizer Inc and its German partner BioNTech SE have applied for emergency use authorization of ...

The family of a Bothell woman found dead is boosting the reward for information that could lead to the killer. 83-year-old Seattle stabbing victim called 911 to report threat before being killed ...

Pfizer and BioNTech said on Tuesday they're seeking emergency use authorization from the US Food and Drug Administration for a Covid-19 vaccine booster for all individuals age 18 and older. The ...

March 1 (Reuters) - Pfizer Inc (PFE.N), opens new tab and its German partner BioNTech SE (22UAy.DE), opens new tab have applied for emergency use authorization of their Omicron-adapted COVID-19 ...